Effect of Dicycloplatin, a Novel Platinum Chemotherapeutical Drug, on Inhibiting Cell Growth and Inducing Cell Apoptosis

Dicycloplatin, a new supramolecular platinum-based antitumor drug, has been approved by the State Food and Administration (SFDA) of China. In this study, we investigated the anticancer activity of dicycloplatin in cancer cells and signaling pathways involved in dicycloplatin-induced apoptosis. Dicyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guang-quan, Chen, Xing-gui, Wu, Xing-ping, Xie, Jing-dun, Liang, Yong-ju, Zhao, Xiao-qin, Chen, Wei-qiang, Fu, Li-wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495782/
https://www.ncbi.nlm.nih.gov/pubmed/23152837
http://dx.doi.org/10.1371/journal.pone.0048994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495782/
https://www.ncbi.nlm.nih.gov/pubmed/23152837
http://dx.doi.org/10.1371/journal.pone.0048994

Ejemplares similares